对《直接作用抗病毒药物治愈丙型肝炎感染后的体重过度增加》的更正
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.
作者信息
Do Albert, Esserman Denise A, Krishnan Supriya, Lim Joseph K, Taddei Tamar H, Hauser Ronald G, Tate Janet P, Re Vincent Lo, Justice Amy C
机构信息
Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar St, 1080 LMP, New Haven, CT, USA.
Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
出版信息
J Gen Intern Med. 2020 Oct;35(10):3140. doi: 10.1007/s11606-020-06227-w.
Abstract
JGIM published the article matched with the editorial in this issue in the July 2020 issue. Our apologies to the authors of the paper and the editorial.
摘要
《普通内科医学杂志》（JGIM）在2020年7月刊上发表了与本期社论相匹配的文章。我们向该论文的作者和社论作者表示歉意。
相似文献
1
Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.
J Gen Intern Med. 2020 Oct;35(10):3140. doi: 10.1007/s11606-020-06227-w.
2
Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.
J Gen Intern Med. 2020 Jul;35(7):2025-2034. doi: 10.1007/s11606-020-05782-6. Epub 2020 Apr 27.
3
Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up.
Z Gastroenterol. 2017 Sep;55(9):848-856. doi: 10.1055/s-0043-112656. Epub 2017 Sep 12.
4
Chronic Hepatitis C and Direct Acting Antivirals.
Surg Pathol Clin. 2018 Jun;11(2):287-296. doi: 10.1016/j.path.2018.02.002. Epub 2018 Mar 26.
5
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.
6
Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients.
CMAJ Open. 2018 Jan 5;6(1):E12-E18. doi: 10.9778/cmajo.20170059.
7
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.
Liver Int. 2017 Aug;37(8):1122-1127. doi: 10.1111/liv.13456. Epub 2017 May 25.
8
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting.
J Hepatol. 2019 Dec;71(6):1076-1085. doi: 10.1016/j.jhep.2019.07.006. Epub 2019 Jul 17.
9
The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.
United European Gastroenterol J. 2017 Aug;5(5):648-657. doi: 10.1177/2050640616678151. Epub 2016 Nov 4.
10
Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project.
Trop Med Int Health. 2020 Sep;25(9):1098-1109. doi: 10.1111/tmi.13450. Epub 2020 Jul 5.
引用本文的文献
1
Metabolic Evaluation in Patients With Hepatitis C Treated With Direct Antiviral Agents.
Front Med (Lausanne). 2021 May 31;8:631600. doi: 10.3389/fmed.2021.631600. eCollection 2021.
Zotero 插件